Kingsview Wealth Management, LLC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 133 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kingsview Wealth Management, LLC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$32,000
-42.9%
10,959
-23.9%
0.00%
-33.3%
Q2 2021$56,000
+7.7%
14,404
-8.0%
0.00%0.0%
Q1 2021$52,000
+15.6%
15,663
-2.2%
0.00%0.0%
Q4 2020$45,000
+40.6%
16,012
+24.0%
0.00%0.0%
Q3 2020$32,000
-77.0%
12,912
+26.4%
0.00%
-78.6%
Q2 2020$139,000
+162.3%
10,212
-6.1%
0.01%
+55.6%
Q2 2019$53,000
-41.8%
10,877
-1.7%
0.01%
-35.7%
Q1 2019$91,00011,0640.01%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Novo Holdings A/S 3,100,000$15,004,0002.10%
DAFNA Capital Management LLC 830,538$4,020,0001.51%
Baupost Group 24,471,453$118,442,0001.07%
Nantahala Capital Management 5,789,561$28,021,0000.86%
Old West Investment Management, LLC 367,870$1,780,0000.84%
Abrams Capital Management 5,656,462$27,377,0000.74%
Sofinnova Investments, Inc. 848,356$4,106,0000.38%
Stanley-Laman Group, Ltd. 312,609$1,513,0000.36%
Nantahala Capital Management 2,000,000$9,680,0000.30%
RICE HALL JAMES & ASSOCIATES, LLC 1,494,070$7,231,0000.24%
View complete list of AKEBIA THERAPEUTICS INC shareholders